Cytokines and fibrogenesis

Seminars in Liver Disease

Volumn 19, Issue 2, 1999, Pages 129-140

  Friedman, Scott L ^a  

^a MOUNT SINAI SCHOOL OF MEDICINE   (United States)

Author keywords

Fibrogenesis; Receptors; Stellate cells

Indexed keywords

CYTOKINE; GAMMA INTERFERON; RETINOID; RETINOL;

CELL PROLIFERATION; CHEMOTAXIS; CHRONIC LIVER DISEASE; CYTOKINE RELEASE; EXTRACELLULAR MATRIX; FIBROGENESIS; LIVER FIBROSIS; NONHUMAN; PRIORITY JOURNAL; RECEPTOR INTRINSIC ACTIVITY; REVIEW; SIGNAL TRANSDUCTION; STELLATE CELL; WOUND HEALING;

EID: 0032794576     PISSN: 02728087     EISSN: None     Source Type: Journal    
DOI: 10.1055/s-2007-1007105     Document Type: Review

References (156)

1. Takahara T, Sollberg S, Muona P, Uitto J. Type VI collagen gene expression in experimental liver fibrosis: Quantitation and spatial distribution of mRNAs, and immunodetection of the protein. Liver 1995;15:78-86
2. Milani S, Grappone C, Pellegrini G, et al. Undulin RNA and protein expression in normal and fibrotic human liver. Hepatology 1994;20:908-916
3. Musso O, Rehn M, Saarela J, et al. Collagen XVIII is localized in sinusoids and basement membranes and is expressed by hepatocytes. Hepatology 1998;27:98-107
4. Frizell E, Liu SL, Abraham A, et al. Expression of SPARC in normal and fibrotic livers. Hepatology 1995;21:847-854
5. Friedman SL, Roll FJ, Boyles J, et al. Maintenance of differentiated phenotype of cultured rai hepatic lipocytes by basement membrane matrix. J Biol Chem 1989;264:10756-10762
6. Bissell DM, Arenson DM, Maher JJ, Roll FJ. Support of cultured hepatocytes by a laminin-rich gel. Evidence for a functionally significant subendothelial matrix in normal rat liver. J Clin Invest 1987;79:801-812
7. Timpl R. Macromolecular organization of basement membranes. Curr Opin Cell Biol 1996;8:618-624
8. Clark EA, Brugge JS. Integrins and signal transduction pathways: The road taken. Science 1995;268:233-239
9. Scoazec JY. Expression of cell-matrix adhesion molecules in the liver and their modulation during fibrosis. J Hepatol 1995;22:20-27
10. Jarnagin WR, Rockey DC, Koteliansky VE, et al. Expression of variant fibronectins in wound healing: Cellular source and biological activity of the EIIIA segment in rat hepatic fibrogenesis. J Cell Biol 1994;127:2037-2048
11. Carloni V, Romanelli RG, Pinzani M, et al. Expression and function of integrin receptors for collagen and laminin in cultured human hepatic stellate cells. Gastroenterology 1996;110:1127-1136
12. Carloni V, Romanelli RG, Pinzani M, et al. Focal adhesion kinase and phospholipase C gamma involvement in adhesion and migration of human hepatic stellate cells. Gastroenterology 1997;112:522-531
13. Racine-Samson L, Rockey DC, Bissell DM. The role of alpha 1 beta 1 integrin in wound contraction. A quantitative analysis of liver myofibroblasts in vivo and in primary culture. J Biol Chem 1997;272:30911-30917
14. Imai K, Senoo H. Morphology of sites of adhesion between hepatic stellate cells (vitamin A-storing cells) and a three-dimensional extracellular matrix. Anat Rec 1998;250:430-437
15. Shrivastava A, Radziejewski C, Campbell E, et al. An orphan receptor tyrosine kinase family whose members serve as nonintegrin collagen receptors. Mol Cell 1997;1:25-34
16. Vogel W, Gish GD, Alves F, Pawson T. The discoidin domain receptor tyrosine kinases are activated by collagen. Mol Cell 1997;1:13-23
17. Ankoma-Sey V, Matli M, Chang KB, et al. Coordinated induction of VEGF receptors in mesenchymal cell types during rat hepatic wound healing. Oncogene 1998;17:115-121
18. Maher JJ, McGuire RF. Extracellular matrix gene expression increases preferentially in rat lipocytes and sinusoidal endothelial cells during hepatic fibrosis in vivo. J Clin Invest 1990;86: 1641-1648
19. Roskams T, Moshage H, De Vos R, et al. Heparan sulfate proteoglycan expression in normal human liver. Hepatology 1995;21: 950-958
20. Rescan PY, Loreal O, Hassell JR, et al. Distribution and origin of the basement membrane component perlecan in rat liver and primary hepatocyte culture. Am J Pathol 1993;142:199-208
21. Gallai M, Kovalszky I, Knittel T, et al. Expression of extracellular matrix proteoglycans perlecan and decorin in carbon-tetrachloride-injured rat liver and in isolated liver cells. Am J Pathol 1996;148:1463-1471
22. Tsukamoto H, Rippe R, Niemela O, Lin M. Roles of oxidative stress in activation of Kupffer and Ito cells in liver fibrogenesis. J Gastroenterol Hepatol 1995;10(suppl 1):S50-53
23. Gressner AM. Cytokines and cellular crosstalk involved in the activation of fat-storing cells. J Hepatol 1995;22:28-36
24. Mathew J, Hines JE, Toole K, et al. Quantitative analysis of macrophages and perisinusoidal cells in primary biliary cirrhosis. Histopathology 1994;25:65-70
25. Johnson SJ, Hines JE, Burt AD. Macrophage and perisinusoidal cell kinetics in acute liver injury. J Pathol 1992;166:351-358
26. Grinko I, Geerts A, Wisse E. Experimental biliary fibrosis correlates with increased numbers of fat-storing and Kupffer cells, and portal endotoxemia. J Hepatol 1995;23:449-458
27. Zerbe O, Gressner AM. Proliferation of fat-storing cells is stimulated by secretions of Kupffer cells from normal and injured liver. Exp Mol Pathol 1988;49:87-101
28. Friedman SL, Arthur MJ. Activation of cultured rat hepatic lipocytes by Kupffer cell conditioned medium. Direct enhancement of matrix synthesis and stimulation of cell proliferation via induction of platelet-derived growth factor receptors. J Clin Invest 1989;84:1780-1785
29. Vyas SK, Leyland H, Gentry J, Arthur MJ. Rat hepatic lipocytes synthesize and secrete transin (stromelysin) in early primary culture. Gastroenterology 1995;109:889-898
30. Leyland H, Gentry J, Arthur MJ, Benyon RC. The plasminogen-activating system in hepatic stellate cells. Hepatology 1996;24: 1172-1178
31. Takahara T, Furui K, Yata Y, et al. Dual expression of matrix metalloproteinase-2 and membrane-type 1-matrix metalloproteinase in fibrotic human livers. Hepatology 1997;26:1521-1529
32. Arthur MJ. Collagenases and liver fibrosis. J Hepatol 1995;22:43-48
33. Milani S, Herbst H, Schuppan D, et al. Differential expression of matrix-metalloproteinase-1 and -2 genes in normal and fibrotic human liver. Am J Pathol 1994;144:528-537
34. Herbst H, Wege T, Milani S, et al. Tissue inhibitor of metalloproteinase-1 and -2 RNA expression in rat and human liver fibrosis. Am J Pathol 1997;150:1647-1659
35. Benyon RC, Iredale JP, Goddard S, et al. Expression of tissue inhibitor of metalloproteinases 1 and 2 is increased in fibrotic human liver. Gastroenterology 1996;110:821-831
36. Iredale JP, Goddard S, Murphy G, et al. Tissue inhibitor of metalloproteinase-I and interstitial collagenase expression in autoimmune chronic active hepatitis and activated human hepatic lipocytes. Clin Sci 1995;89:75-81
37. Iredale JP, Benyon RC, Arthur MJ, et al. Tissue inhibitor of metalloproteinase-1 messenger RNA expression is enhanced rela-tive to interstitial collagenase messenger RNA in experimental liver injury and fibrosis. Hepatology 1996;24:176-184
38. Iredale JP. Tissue inhibitors of metalloproteinases in liver fibrosis. Int J Biochem Cell Biol 1997;29:43-54
39. Arthur MJ, Stanley A, Iredale JP, et al. Secretion of 72 kDa type IV collagenase/gelatinase by cultured human lipocytes. Analysis of gene expression, protein synthesis and proteinase activity. Biochem J 1992;287:701-707
40. Milani S, Herbst H, Schuppan D, et al. Differential expression of matrix-metalloproteinase-1 and -2 genes in normal and fibrotic human liver. Am J Pathol 1994;144:528-537
41. Poulos JE, Baldassare JJ, Bacon BR, et al. Fibronectin and cytokines increase JNK, ERK, AP-1 activity, and transin gene expression in rat hepatic stellate cells. Am J Physiol 1997;273: G804-811
42. Theret N, Musso O, L'Helgoualc'h A, Clement B. Activation of matrix metalloproteinase-2 from hepatic stellate cells requires interactions with hepatocytes. Am J Pathol 1997;150:51-58
43. Winwood PJ, Schuppan D, Iredale JP, et al. Kupffer cell-derived 95-kd type IV collagenase/gelatinase B: Characterization and expression in cultured cells. Hepatology 1995;22:304-315
44. Wang SC, Tsukamoto H, Rippe RA, et al. Expression of interleukin-10 by in vitro and in vivo activated hepatic stellate cells. J Biol Chem 1998;273:302-308
45. Rockey DC, Chung JJ. Interferon gamma inhibits lipocyte activation and extracellular matrix mRNA expression during experimental liver injury: Implications for treatment of hepatic fibrosis. J Invest Med 1994;42:660-670
46. Baker SJ, Reddy EP. Transducers of life and death: TNF receptor superfamily and associated proteins. Oncogene 1996;12:1-9
47. Unemori EN, Pickford LB, Salles AL, et al. Relaxin induces an extracellular matrix-degrading phenotype in human lung fibroblasts in vitro and inhibits lung fibrosis in a murine model in vivo. J Clin Invest 1996;98:2739-2745
48. Schwabe C, Bullesbach EE. Relaxin: Structures, functions, promises, and nonevolution. FASEB J 1994;8:1152-1160
49. Schuppan D, Schmid M, Somasundaram R, et al. Collagens in the liver extracellular matrix bind hepatocyte growth factor. Gastroenterology 1998;114:139-152
50. Somasundaram R, Schuppan D. Type I, II, III, IV, V, and VI collagens serve as extracellular ligands for the isoforms of platelet-derived growth factor (AA, BB, and AB). J Biol Chem 1996;271:26884-26891
51. Taipale J, Keski-Oja J. Growth factors in the extracellular matrix. FASEB J 1997;11:51-59
52. Pinzani M, Marra F, Carloni V. Signal transduction in hepatic stellate cells. Liver 1998;18:2-13
53. Marra F, Choudhury GG, Pinzani M, Abboud HE. Regulation of platelet-derived growth factor secretion and gene expression in human liver fat-storing cells. Gastroenterology 1994;107: 1110-1117
54. Claesson-Welsh L. Signal transduction by the PDGF receptors. Prog Growth Factor Res 1994;5:37-54
55. Roth S, Kuhl K, Gressner AM. Subcellular localization of (latent) TGFbeta and latent TGFbeta binding protein (LTBP-1) in rat hepatocytes and hepatic stellate cells. Hepatology 1998;28:1588-1596
56. Gong W, Gressner AM, Michel K, Roth S. Isoforms and splice variant of transforming growth factor beta-binding protein in rat hepatic stellate cells. Gastroenterology 1998;114:352-363
57. Okuno M, Moriwaki H, Imai S, et al. Retinoids exacerbate rat liver fibrosis by inducing the activation of latent TGF-beta in liver stellate cells [see comments]. Hepatology 1997;26:913-921
58. Crawford SE, Stellmach V, Murphy-Ullrich JE, et al. Thrombospondin-1 is a major activator of TGF-beta1 in vivo. Cell 1998;93:1159-1170
59. Knittel T, Fellmer P, Ramadori G. Gene expression and regulation of plasminogen activator inhibitor type I in hepatic stellate cells of rat liver. Gastroenterology 1996;111:745-754
60. Scoazec JY, Flejou JF, D'Errico A, et al. Focal nodular hyperplasia of the liver: Composition of the extracellular matrix and expression of cell-cell and cell-matrix adhesion molecules. Hum Pathol 1995;26:1114-1125
61. Wong L, Yamasaki G, Johnson RJ, Friedman SL. Induction of beta-platelet-derived growth factor receptor in rat hepatic lipocytes during cellular activation in vivo and in culture. J Clin Invest 1994;94:1563-1569
62. Friedman SL, Yamasaki G, Wong L. Modulation of transforming growth factor beta receptors of rat lipocytes during the hepatic wound healing response. Enhanced binding and reduced gene expression accompany cellular activation in culture and in vivo. J Biol Chem 1994;269:10551-10558
63. Marra F, DeFranco R, Grappone C, et al. Expression of the thrombin receptor in human liver: Up-regulation during acute and chronic injury. Hepatology 1998;27:462-471
64. Eriksson A, Siegbahn A, Westermark B, et al. PDGF alpha-and beta-receptors activate unique and common signal transduction pathways. EMBO J 1992;11:543-550
65. Friedman SL. Closing in on the signals of hepatic fibrosis [editorial: comment]. Gastroenterology 1997;112:1406-1409
66. Pinkas-Kramarski R, Soussan L, Waterman H, et al. Diversification of Neu differentiation factor and epidermal growth factor signaling by combinatorial receptor interactions. EMBO J 1996; 15:2452-2467
67. Wrana JL, Attisano L, Wieser R, et al. Mechanism of activation of the TGF-beta receptor. Nature 1994;370:341-347
68. Heldin CH. Dimerization of cell surface receptors in signal transduction. Cell 1995;80:213-223
69. Carraway KLR, Cantley LC. A neu acquaintance for erbB3 and erbB4: A role for receptor heterodimerization in growth signaling. Cell 1994;78:5-8
70. David M, Petricoin ER, Benjamin C, et al. Requirement for MAP kinase (ERK2) activity in interferon alpha-and interferon beta-stimulated gene expression through STAT proteins [see comments]. Science 1995;269:1721-1723
71. de Caestecker MP, Parks WT, Frank CJ, et al. Smad2 transduces common signals from receptor serine-threonine and tyrosine kinases. Genes Dev 1998;12:1587-1592
72. Reinehr RM, Kubitz R, Peters-Regehr T, et al. Activation of rat hepatic stellate cells in culture is associated with increased sensitivity to endothelin-1. Hepatology 1998;28:1566-1577
73. Housset C, Rockey DC, Bissell DM. Endothelin receptors in rat liver: Lipocytes as a contractile target for endothelin 1. Proc Natl Acad Sci USA 1993;90:9266-9270
74. Johnson RJ, Iida H, Alpers CE, et al. Expression of smooth muscle cell phenotype by rat mesangial cells in immune complex nephritis. Alpha-smooth muscle actin is a marker of mesangial cell proliferation. J Clin Invest 1991;87:847-858
75. Kapanci Y, Kurt AM, Redard M, Gabbiani G. Phenotypic modulation of alveolar myofibroblasts in transplanted human lungs. Mod Pathol 1997;10:1134-1142
76. 4-induced fibrotic rat livers. Hepatology 1996;23:1538-1545
77. Ballardini G, Groff P, Badiali dGL, et al. Ito cell heterogeneity: Desmin-negative Ito cells in normal rat liver. Hepatology 1994; 19:440-446
78. Ramm GA, Britton RS, O'Neill R, et al. Vitamin A-poor lipocytes: A novel desmin-negative lipocyte subpopulation, which can be activated to myofibroblasts. Am J Physiol 1995; 269:G532-541
79. Rockey DC, Friedman SL. Cytoskeleton of liver perisinusoidal cells (lipocytes) in normal and pathological conditions. Cell Motil Cytoskeleton 1992;22:227-234
80. Niki T, Pekny M, Hellemans K, et al. Class VI intermediate filament protein nestin is induced during activation of rat hepatic stellate cells. Hepatology 1999;29:520-527
81. Friedman SL. Hepatic stellate cells. Prog Liver Dis 1996;14: 101-130
82. Gressner AM. Transdifferentiation of hepatic stellate cells (Ito cells) to myofibroblasts: A key event in hepatic fibrogenesis. Kidney Int 1996;54(suppl):S39-45
83. Friedman SL. Seminars in medicine of the Beth Israel Hospital, Boston. The cellular basis of hepatic fibrosis. Mechanisms and treatment strategies. N Engl J Med 1993;328:1828-1835
84. Okuno M, Moriwaki H, Imai S, et al. Retinoids exacerbate rat liver fibrosis by inducing the activation of latent TGFbeta in liver stellate cells. Hepatology 1997;913-921
85. Lee KS, Buck M, Houglum K, Chojkier M. Activation of hepatic stellate cells by TGF alpha and collagen type I is mediated by oxidative stress through c-myb expression. J Clin Invest 1995; 96:2461-2468
86. Hernandez-Munoz I, de la Torre P, Sanchez-Alcazar JA, et al. Tumor necrosis factor alpha inhibits collagen alpha 1(I) gene expression in rat hepatic stellate cells through a G protein. Gastroenterology 1997;113:625-640
87. Sprenger H, Kaufmann A, Garn H, et al. Induction of neutrophil-attracting chemokines in transforming rat hepatic stellate cells. Gastroenterology 1997;113:277-285
88. Taub R. Blocking NF-kappaB in the liver: The good and bad news [editorial; comment]. Hepatology 1998;27:1445-1446
89. Hellerbrand C, Jobin C, Iimuro Y, Licato L, Sartor RB, Brenner DA. Inhibition of NFkappaB in activated rat hepatic stellate cells by proteasome inhibitors and an IkappaB super-repressor [see comments]. Hepatology 1998;27:1285-1295
90. Hellerbrand, Wang SC, Tsukamoto H, et al. Expression of intracellular adhesion molecule 1 by activated hepatic stellate cells. Hepatology 1996;24:670-676
91. Kawada N, Uoya M, Seki S, et al. Regulation by cAMP of STAT2 activation in hepatic stellate cells. Biochem Biophys Res Commun 1997;233:464-469
92. Rippe RA, Almounajed G, Brenner DA. Sp1 binding activity increases in activated Ito cells. Hepatology 1995;22:241-251
93. Lalazar A, Wong L, Yamasaki G, Friedman SL. Early genes induced in hepatic stellate cells during wound healing. Gene 1997;195:235-243
94. Koritschoner NP, Bocco JL, Panzetta-Dutari GM, et al. A novel human zinc finger protein that interacts with the core promoter element of a TATA box-less gene. J Biol Chem 1997;272: 9573-9580
95. Ratziu V, Lalazar A, Wong L, et al. Zf9, a Kruppel-like transcription factor upregulated in vivo during early hepatic fibrosis. Proc Natl Acad Sci USA 1998;95:9500-9505
96. Kim Y, Ratziu V, Choi S-G, et al. Transcriptional activation of TGFbeta1 and its receptors by the Kruppel-like factor Zf9/CPBP and Sp1; potential mechanisms for autocrine fibrogenesis in response to injury. J Biol Chem 1998;273:33750-33758
97. Hunter T. The Croonian Lecture 1997. The phosphorylation of proteins on tyrosine: Its role in cell growth and disease. Philos Trans R Soc Lond B Biol Sci 1998;353:583-605
98. Hubbard SR, Mohammadi M, Schlessinger J. Autoregulatory mechanisms in protein-tyrosine kinases. J Biol Chem 1998;273: 11987-11990
99. Pinzani M, Milani S, Grappone C, et al. Expression of platelet-derived growth factor in a model of acute liver injury. Hepatology 1994;19:701-707
100. Marra F, Gentilini A, Pinzani M, et al. Phosphatidylinositol 3-kinase is required for platelet-derived growth factor's actions on hepatic stellate cells [see comments]. Gastroenterology 1997; 112:1297-1306
101. Failli P, Ruocco C, De FR, et al. The mitogenic effect of platelet-derived growth factor in human hepatic stellate cells requires calcium influx. Am J Physiol 1995:C1133-1139
102. Di Sario A, Baroni GS, Bendia E, et al. Characterization of ion transport mechanisms regulating intracellular pH in hepatic stellate cells. Am J Physiol 1997;273:G39-48
103. 2+ exchanger emerges in hepatic stellate cells after activation in association with liver fibrosis. Proc Natl Acad Sci USA 1998;95:5389-5394
104. Houglum K, Lee KS, Chojkier M. Proliferation of hepatic stellate cells is inhibited by phosphorylation of CREB on serine 133. J Clin Invest 1997;99:1322-1328
105. Rockey DC, Fouassier L, Chung JJ, et al. Cellular localization of endothelin-1 and increased production in liver injury in the rat: Potential for autocrine and paracrine effects on stellate cells. Hepatology 1998;27:472-480
106. Pinzani M, Milani S, De Franco R, et al. Endothelin I is overexpressed in human cirrhotic liver and exerts multiple effects on activated hepatic stellate cells. Gastroenterology 1996;110: 534-548
107. Kawada N, Kuroki T, Kobayashi K, et al. Action of endothelins on hepatic stellate cells. J Gastroenterol 1995;30:731-738
108. Mallat A, Preaux AM, Serradeil-Le Gal C, et al. Growth inhibitory properties of endothelin-1 in activated human hepatic stellate cells: A cyclic adenosine monophosphate-mediated pathway. Inhibition of both extracellular signal-regulated kinase and c-Jun kinase and upregulation of endothrlin B receptors. J Clin Invest 1996;98:2771-2778
109. Marra F, Grandaliano G, Valente AJ, Abboud HE. Thrombin stimulates proliferation of liver fat-storing cells and expression of monocyte chemotactic protein-1 : Potential role in liver injury. Hepatology 1995;22:780-787
110. Rosenbaum J, Blazejewski S, Preaux AM, et al. Fibroblast growth factor 2 and transforming growth factor beta 1 interactions in human liver myofibroblasts. Gastroenterology 1995; 109:1986-1996
111. Skrtic S, Wallenius V, Ekberg S, et al. Insulin-like growth factors stimulate expression of hepatocyte growth factor hut not transforming growth factor beta1 in cultured hepatic stellate cells. Endocrinology 1997;138:4683-4689
112. Pinzani M, Abboud HE, Aron DC. Secretion of insulin-like growth factor-I and binding proteins by rat liver fat-storing cells: Regulatory role of platelet-derived growth factor. Endocrinology 1990;127:2343-2349
113. Maher JJ. Cell-specific expression of hepatocyte growth factor in liver. Upregulation in sinusoidal endothelial cells after carbon tetrachloride. J Clin Invest 1993;91:2244-2252
114. Reimann T, Hempel U, Krautwald S, et al. Transforming growth factor-beta1 induces activation of Ras, Raf-1, MEK and MAPK in rat hepatic stellate cells. FEBS Lett 1997;403:57-60
115. Ankoma-Sey V, Tzagarakis C, Chang KB, Friedman SL. Down-regulation of matrix and beta-PDGF receptor gene expression by anti-TGFbeta antibody in rat hepatic stellate cells during experimental liver injury. Int Hepatol Commun 1997;6:144-152
116. Rosenbaum J, Blazejewski S. Regulation of Ito cell proliferation by soluble factors. J Hepatol 1995;22:65-70
117. Rockey DC. The cellular pathogenesis of portal hypertension: Stellate cell contractility, endothelin, and nitric oxide. Hepatology 1997;25:2-5
118. Rockey DC, Weisiger RA. Endothelin induced contractility of stellate cells from normal and cirrhotic rat liver: Implications for regulation of portal pressure and resistance. Hepatology 1996; 24:233-240
119. Bauer M, Paquette NC, Zhang JX, et al. Chronic ethanol consumption increases hepatic sinusoidal contractile response to endothelin-1 in the rat. Hepatology 1995;22:1565-1576
120. Bataller R, Nicolas JP, Gines P, et al. Arginine vasopressin induces contraction and stimulates growth of cultured human hepatic stellate cells. Gastroenterology 1997;113:615-624
121. Kawada N, Klein H, Decker K. Eicosanoid-mediated contractility of hepatic stellate cells. Biochem J 1992;285:367-371
122. Kawada N, Inoue M. Effect of adrenomedullin on hepatic pericytes (stellate cells) of the rat. FEBS Lett 1994;356:109-113
123. Rockey DC, Chung JJ. Inducible nitric oxide synthase in rat hepatic lipocytes and the effect of nitric oxide on lipocyte contractility. J Clin Invest 1995;95:1199-1206
124. Castilla A, Prieto J, Fausto N. Transforming growth factors beta 1 and alpha in chronic liver disease. Effects of interferon alfa therapy [see comments]. N Engl J Med 1991;324:933-940
125. Gressner AM, Bachem MG. Molecular mechanisms of liver fibrogenesis - A homage to the role of activated fat-storing cells. Digestion 1995;56:335-346
126. Bissell DM, Wang SS, Jarnagin WR, Roll FJ. Cell-specific expression of transforming growth factor-beta in vat liver. Evidence for autocrine regulation of hepatocyte proliferation. J Clin Invest 1995;96:447-455
127. Ji C, Casinghino S, McCarthy TL, Centrella M. Multiple and essential Sp1 binding sites in the promoter for transforming growth factor-beta type I receptor. J Biol Chem 1997;272: 21260-21267
128. Ratziu R, Kim SJ, Kim YS, et al. A key role for Zf9 in hepatic fibrosis via its transcriptional activation of TGFb1 and types I and II TGFb receptors genes in rat stellate cells. Hepatology 1997;26:185A( Abstract)
129. Michel K, Roth S, Trautwein C, et al. Analysis of the expression pattern of the latent transforming growth factor beta binding protein isoforms in normal and diseased human liver reveals a new splice variant missing the proteinase-sensitive hinge region. Hepatology 1998;27:1592-1599
130. Attisano L, Wrana JL. Mads and Smads in TGF beta signalling. Curr Opin Cell Biol 1998;10:188-194
131. Wrana JL, Attisano L. MAD-related proteins in TGF-beta signalling. Trends Genet 1996;12:493-496
132. Heldin CH, Miyazono K, ten Dijke P. TGF-beta signalling from cell membrane to nucleus through SMAD proteins. Nature 1997;390:465-471
133. van der Zee E, Everts V, Beertsen W. Cytokines modulate routes of collagen breakdown. Review with special emphasis on mechanisms of collagen degradation in the periodontium and the burst hypothesis of periodontal disease progression. J Clin Periodontal 1997;24:297-305
134. Hautekeete ML, Geerts A. The hepatic stellate (Ito) cell: Its role in human liver disease. Virchows Arch 1997;430:195-207
135. Ries C, Petrides PE. Cytokine regulation of matrix metalloproteinase activity and its regulatory dysfunction in disease. Biol Chem Hoppe-Seyler 1995;376:345-355
136. Bienkowski RS, Gotkin MG. Control of collagen deposition in mammalian lung. Proc Soc Exp Biol Med 1995;209:118-140
137. Rieder H, Armbrust T, Meyer zum Buschenfelde KH, Ramadori G. Contribution of sinusoidal endothelial liver cells to liver fibrosis: Expression of transforming growth factor-beta 1 receptors and modulation of plasmin-generating enzymes by transforming growth factor-beta 1. Hepatology 1993;18:937-944
138. Marra F, Romanelli RG, Pastacaldi S, et al. Monocyte chemotactic protein-1 as a chemoattractant for human hepatic stellate cells. Hepatology 1999;29:140-148
139. Marra F, DeFranco R, Grappone C, et al. Increased expression of monocyte chemotactic protein-1 during active hepatic fibrogenesis: Correlation with monocyte infiltration. Am J Pathol 1998;152:423-430
140. Marra F, Valente AJ, Pinzani M, Abboud HE. Cultured human liver fat-storing cells produce monocyte chemotactic protein-1. Regulation by proinflammatory cytokines. J Clin Invest 1993; 92:1674-1680
141. Marra F, Pastacaldi S, Romanelli RG, et al. Integrin-mediated stimulation of monocyte chemotactic protein-1 expression. FEBS Lett 1997;414:221-225
142. van Hogezand RA, Verspaget HW. New therapies for inflammatory bowel disease: An update on chimeric anti-TNF alpha antibodies and IL-10 therapy. Scand J Gastroenterol 1997;223(suppl): 105-107
143. Thompson KC, Trowern A, Fowell A, et al. Primary rat and mouse hepatic stellate cells express the macrophage inhibitor cytokine interleukin 10 during the course of activation in vitro. Hepatology 1998;28:1518-1524
144. Thompson K, Maltby J, Fallowfield J, et al. Interleukin-10 expression and function in murine liver inflammation and fibrosis. Hepatology 1998;(in press)
145. Napoli J, Bishop GA, McGuinness PH, et al. Progressive liver injury in chronic hepatitis C infection correlates with increased intrahepatic expression of Th1-associated cytokines. Hepatology 1996;24:759-765
146. Friedman SL, Wei S, Blaner WS, Retinol release by activated rat hepatic lipocytes: Regulation by Kupffer cell-conditioned medium and PDGF. Am J Physiol 1993;264:G947-G952
147. Okuno M, Sato T, Kitamoto T, et al. Increased 9,13-di-cis-retinoic acid in rat hepatic fibrosis: A potential link between retinoid loss and TGF-β mediated fibrogenesis via RARa activation. J Hepatol 1999; in press
148. Roth S, Michel K, Gressner AM. (Latent) transforming growth factor beta in liver parenchymal cells, its injury-dependent release, and paracrine effects on rat hepatic stellate cells. Hepatology 1998;27:1003-1012
149. Qi Z, Atsuchi N, Ooshima A, Takeshita A, Ueno H. Blockade of type beta transforming growth factor signaling prevents liver fibrosis and dysfunction in the rat [In Process Citation). Proc Natl Acad Sci USA 1999;96:2345-2349
150. Iimuro Y, Gallucci RM, Luster MI, Kono H, Thurman RG. Antibodies to tumor necrosis factor alfa attenuate hepatic necrosis and inflammation caused by chronic exposure to ethanol in the rat. Hepatology 1997;26:1530-1537
151. Luscher TF, Wenzel RR. Endothelin and endothelin antagonists: Pharmacology and clinical implications. Agents Actions 1995; 45(suppl):237-253
152. Rockey DC, Chung JJ. Endothelin antagonism in experimental hepatic fibrosis. Implications for endothelin in the pathogenesis of wound healing. J Clin Invest 1996;98:1381-1388
153. Lawrence DS, Niu J. Protein kinase inhibitors: The tyrosine-specific protein kinases. Pharmacol Ther 1998;77:81-114
154. Franklin TJ. Therapeutic approaches to organ fibrosis. Int J Biochem Cell Biol 1997;29:79-89
155. Seibold JR, Clements PJ, Furst DE, et al. Safety and pharmacokinetics of recombinant human relaxin in systemic sclerosis. J Rheumatol 1998;25:302-307
156. Rockey DC, Maher JJ, Jarnagin WR, et al. Inhibition of hepatic lipocyte activation in culture by interferon-gamma. Hepatology 1992;16:776-778